These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Antithrombotic treatment in chronic nonrheumatic atrial fibrillation]. Koskinen P; Kupari M; Halinen MO Duodecim; 1993; 109(19):1631-7. PubMed ID: 7736980 [No Abstract] [Full Text] [Related]
24. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients. Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069 [TBL] [Abstract][Full Text] [Related]
25. Digoxin in the aged. Kirsten E; Rodstein M; Iuster Z Geriatrics; 1973 Jan; 28(1):95-101. PubMed ID: 4683094 [No Abstract] [Full Text] [Related]
26. [Anticoagulation therapy in paroxysmal atrial fibrillation]. Risøe C; Gjesdal K Tidsskr Nor Laegeforen; 2004 Apr; 124(7):950-2. PubMed ID: 15060644 [TBL] [Abstract][Full Text] [Related]
27. MI survivors: using drug therapies to protect the heart. Amidon TM Geriatrics; 1995 Oct; 50(10):26-8, 31-4, 36. PubMed ID: 7557489 [TBL] [Abstract][Full Text] [Related]
28. One weapon, two blows in the war against the thrombus. Sen-Chowdhry S; Gordon RJ J Am Coll Cardiol; 2014 Jun; 63(24):2699-701. PubMed ID: 24794117 [No Abstract] [Full Text] [Related]
29. Use of digoxin for heart failure and atrial fibrillation in elderly patients. Cheng JW; Rybak I Am J Geriatr Pharmacother; 2010 Oct; 8(5):419-27. PubMed ID: 21335295 [TBL] [Abstract][Full Text] [Related]
30. What is the optimal medical management of ischemic heart failure? Cleland JG; Alamgir F; Nikitin NP; Clark AL; Norell M Prog Cardiovasc Dis; 2001; 43(5):433-55. PubMed ID: 11251129 [TBL] [Abstract][Full Text] [Related]
31. [Clinical characteristics and antithrombotic therapy for stroke prevention in patients with atrial fibrillation]. Tsuzuki N Hokkaido Igaku Zasshi; 2002 Nov; 77(6):563-70. PubMed ID: 12491628 [No Abstract] [Full Text] [Related]
32. Low dose warfarin and aspirin in preventing IHD. Meade T Practitioner; 1998 Nov; 242(1592):799-803. PubMed ID: 10441895 [No Abstract] [Full Text] [Related]
33. The "pill-in-the-pocket" approach to atrial fibrillation. Grönefeld GC; Hohnloser SH N Engl J Med; 2005 Mar; 352(11):1150-1; author reply 1150-1. PubMed ID: 15784671 [No Abstract] [Full Text] [Related]
34. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation. Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115 [TBL] [Abstract][Full Text] [Related]
35. New thoughts of pathophysiology and therapy of ischemic heart disease. Pepine CJ Cardiologia; 1991 Dec; 36(12 Suppl 1):373-7. PubMed ID: 1841793 [TBL] [Abstract][Full Text] [Related]
36. Adjuvant therapy for atrial fibrillation. Mohammed KS; Kowey PR; Musco S Future Cardiol; 2010 Jan; 6(1):67-81. PubMed ID: 20014988 [TBL] [Abstract][Full Text] [Related]
37. Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling. Healey JS; Morillo CA; Connolly SJ Curr Opin Cardiol; 2005 Jan; 20(1):31-7. PubMed ID: 15596957 [TBL] [Abstract][Full Text] [Related]
38. Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST-elevation myocardial infarction (PRISM-PLUS Study). Huynh T; Theroux P; Snapinn S; Wan Y; Am Heart J; 2003 Oct; 146(4):668-73. PubMed ID: 14564321 [TBL] [Abstract][Full Text] [Related]
39. Role of antithrombotic therapy in atrial fibrillation. Sethi KK; Sudha R Indian Heart J; 1993; 45(6):451-7. PubMed ID: 8070820 [No Abstract] [Full Text] [Related]